Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort

In adults hospitalised with RSV-associated ARI, simple age-based heuristics-including the UK ≥75-year threshold-showed only modest ability to discriminate risk of ICU/HDU admission/60-day mortality once hospitalised. Comorbidity-inclusive approaches may provide more informative hospital-level risk stratification and warrant evaluation in future RSV vaccine-effectiveness and outcome studies. Any application requires external validation, more systematic RSV testing and comparison with physiology-based scores in larger, vaccinated cohorts.

Authors

Institutions

Publication Details

Journal
Thorax
Published
2026-02-05
DOI
https://doi.org/10.1136/thorax-2025-224192
Citations
1
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
31.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort

George Hulston, Dexter Wiseman, Sarah Denny, Karl J. Staples et al.
1 citations
Thorax
Respiratory viral infections research
31.52
article

Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort

George Hulston, Dexter Wiseman, Sarah Denny, Karl J. Staples, J Panaguiton, Martha Purcell, Alex Allen, Abigail Jones, Huw Ellis, Matthew Pavitt, Philip Mitchelmore, Tom Wilkinson, Cyrus Daneshvar, TW Clark, Stefan John Marciniak, Rachel Patel, Anna Freeman, James Myerson, A Lea, Paul Hong Lee, Hans Siy-yap, Anluan Keating, Pedro Rodrigues, James D. Chalmers, Ida Saidy, Emma A Davies, Tommaso Morelli, Michael G Crooks, Tom Lewis, Sharon Weinberg, Aruna T Bansal
article en
1 citations

Abstract

In adults hospitalised with RSV-associated ARI, simple age-based heuristics-including the UK ≥75-year threshold-showed only modest ability to discriminate risk of ICU/HDU admission/60-day mortality once hospitalised. Comorbidity-inclusive approaches may provide more informative hospital-level risk stratification and warrant evaluation in future RSV vaccine-effectiveness and outcome studies. Any application requires external validation, more systematic RSV testing and comparison with physiology-based scores in larger, vaccinated cohorts.

Thorax
St Thomas' Hospital (GB), University of Leicester (GB), Royal Devon & Exeter NHS Foundation Trust (GB), Royal Papworth Hospital (GB), Chelsea and Westminster Hospital NHS Foundation Trust (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Ninewells Hospital (GB), University Hospital Southampton NHS Foundation Trust (GB), Manchester University NHS Foundation Trust (GB), University Hospitals Sussex NHS Foundation Trust (GB), Plymouth Hospital (GB), University Hospitals Plymouth NHS Trust (GB), University of Southampton (GB), Imperial College London (GB), Hull York Medical School (GB)
University of Southampton
Reduced inequalities
Openalex Percentile: Top 1%
Respiratory viral infections research
31.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.